Next Step On the Innovation Pathway: Renal Disease Devices

FDA issued an “innovation challenge” Jan. 12 asking companies developing devices for end-stage renal disease to volunteer for a pilot program designed to assess new statistical tools and collaborative processes that the agency hopes will accelerate product development.

FDA’s device center is looking for a few firms focused on next-generation devices for managing end-stage renal disease to help it test new tools and processes designed to jumpstart early-stage product development.

One company has already said it wants to participate.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation